SomnoMed Limited (ASX:SOM)

Market Cap	119.40M +28.5%
Revenue (ttm)	118.50M +18.2%
Net Income	-2.56M
EPS	-0.01
Shares Out	219.08M
PE Ratio	n/a
Forward PE	24.66
Dividend	n/a
Ex-Dividend Date	n/a

Volume	65,916
Average Volume	30,235
Open	0.5700
Previous Close	0.5700
Day's Range	0.5400 - 0.5700
52-Week Range	0.4800 - 0.9450
Beta	0.84
RSI	39.19
Earnings Date	Feb 26, 2026

About SomnoMed

SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. It offers SomnoDent, an oral appliance for obstructive sleep apnea; SomnoBrux, a dental guard for the treatment of teeth grinding damage; SomMorning Repositioner, which help return mandible back to its pre-treatment centric position; and SomTabs for cleaning oral devices. The company was incorporated in 1987 and is headquartered in Crows Nest, Aus...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: SOM

Financial Performance

In fiscal year 2025, SomnoMed's revenue was 111.49 million, an increase of 21.65% compared to the previous year's 91.65 million. Losses were -3.46 million, -71.77% less than in 2024.